CHANGE OF CHIEF EXECUTIVE OFFICER AND REDESIGNATION OF DIRECTOR
(WorldNews Netherlands)

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Genscript Biotech Corporation é‡`æ–¯ç`žç”Ÿç‰©ç§`技股份有é™�å…¬å�¸ * (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1548) CHANGE OF CHIEF EXECUTIVE OFFICER AND REDESIGNATION OF DIRECTOR The Board announces that with effect from 2 August 2020: Dr. Zhang Fangliang has resigned from the position of chief executive officer of the...